<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-13T18:51:15Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2072/466447" metadataPrefix="qdc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2072/466447</identifier><datestamp>2026-03-28T08:24:44Z</datestamp><setSpec>com_2072_98</setSpec><setSpec>col_2072_378192</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Physicochemical properties of lipoproteins assessed by nuclear magnetic resonance as a predictor of premature cardiovascular disease. Presarv-sea study</dc:title>
   <dc:creator>Fernández-Cidón, Bárbara</dc:creator>
   <dc:creator>Candás-Estébanez, Beatriz</dc:creator>
   <dc:creator>Gil-Serret, Miriam</dc:creator>
   <dc:creator>Amigó, Núria</dc:creator>
   <dc:creator>Corbella, Emili</dc:creator>
   <dc:creator>Rodríguez-Sánchez, M. Ángeles</dc:creator>
   <dc:creator>Padró i Miquel, Ariadna</dc:creator>
   <dc:creator>Brotons, Carlos</dc:creator>
   <dc:creator>Hernández-Mijares, Antonio</dc:creator>
   <dc:creator>Calmarza, Pilar</dc:creator>
   <dc:creator>Jarauta, Estíbaliz</dc:creator>
   <dc:creator>Brea-Hernando, Ángel</dc:creator>
   <dc:creator>Mauri Pont, Marta</dc:creator>
   <dc:creator>Guijarro, Carlos</dc:creator>
   <dc:creator>Vila, Àlex</dc:creator>
   <dc:creator>Valdivielso, Pedro</dc:creator>
   <dc:creator>Corbella, Xavier</dc:creator>
   <dc:creator>Pintó, Xavier</dc:creator>
   <dc:subject>NMR analysis of lipoproteins</dc:subject>
   <dc:subject>Lipid profile</dc:subject>
   <dc:subject>Premature cardiovascular disease</dc:subject>
   <dc:subject>Residual cardiovascular risk</dc:subject>
   <dc:subject>Small dense LDL</dc:subject>
   <dc:subject>Lipoprotein particle number</dc:subject>
   <dc:subject>Lipoprotein precipitation</dc:subject>
   <dcterms:abstract>Altres ajuts: Fondo Europeo de Desarrollo Regional (FEDER).</dcterms:abstract>
   <dcterms:abstract>Some lipoprotein disorders related to the residual risk of premature cardiovascular disease (PCVD) are not detected by the conventional lipid profile. In this case-control study, the predictive power of PCVD of serum sdLDL-C, measured using a lipoprotein precipitation method, and of the physicochemical properties of serum lipoproteins, analyzed by nuclear magnetic resonance (NMR) techniques, were evaluated. We studied a group of patients with a first PCVD event (n = 125) and a group of control subjects (n = 190). Conventional lipid profile, the size and number of Very Low Density Lipoproteins (VLDL), Low Density Lipoproteins (LDL), High Density Lipopro-teins (HDL) particles, and the number of particles of their subclasses (large, medium, and small) were measured. Compared to controls, PCVD patients had lower concentrations of all LDL parti-cles, and smaller and larger diameter of LDL and HDL particles, respectively. PCVD patients also showed higher concentrations of small dense LDL-cholesterol (sdLDL), and triglycerides (Tg) in LDL and HDL particles (HDL-Tg), and higher concentrations of large VLDL particles. Multivariate logistic regression showed that sdLDL-C, HDL-Tg, and large concentrations of LDL particles were the most powerful predictors of PCVD. A strong relationship was observed between increased HDL-Tg concentrations and PCVD. This study demonstrates that beyond the conventional lipid profile, PCVD patients have other atherogenic lipoprotein alterations that are detected by magnetic resonance imaging (MRI) analysis.</dcterms:abstract>
   <dcterms:issued>2021</dcterms:issued>
   <dc:type>Article</dc:type>
   <dc:relation>Ministerio de Economía y Competitividad PI16/01094</dc:relation>
   <dc:relation>Instituto de Salud Carlos III PI19/01032</dc:relation>
   <dc:relation>Journal of clinical medicine ; Vol. 10 Núm. 7 (january 2021), p. 1379</dc:relation>
   <dc:rights>open access</dc:rights>
   <dc:rights>Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.</dc:rights>
   <dc:rights>https://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:publisher/>
</qdc:qualifieddc></metadata></record></GetRecord></OAI-PMH>